Palatability of a Novel Oral Formulation of Prednsione

Completed

Conditions studied: Palatability

In brief

Prednisone solution USP (5mg/5mL), is the most commonly prescribed formulation of prednisone to pediatric and adult patients. The rationale for this study is that palatability is the most important determinant of pediatric patient compliance, and therefore, it is critical that the Orbis formulation be perceived as significantly more palatable compared to today's commercially available products in order to warrant further development of the TP.

Key facts

Study ID
NCT02233959
Run by
Arkansas Children's Hospital Research Institute
People needed
24
Starts
2015-12-01
Expected to finish
2016-01-01
Last updated by the study team
2016-02-18

Who can join

Age: 18 and older, up to 32. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.